| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |